THE USE OF CROSS-LINKED HEMOGLOBIN IN TREATING SUBARACHNOID HEMORRHAGE
    1.
    发明申请
    THE USE OF CROSS-LINKED HEMOGLOBIN IN TREATING SUBARACHNOID HEMORRHAGE 审中-公开
    交联HEMOGLOBIN在治疗子宫内膜异位症中的应用

    公开(公告)号:WO1996032130A1

    公开(公告)日:1996-10-17

    申请号:PCT/US1996004776

    申请日:1996-04-08

    CPC classification number: A61K38/42

    Abstract: Cross-linked hemoglobin infusion following subarachnoid hemorrhage dramatically reduces the tissue area of hypoperfusion and reduces the extent of neuronal damage in the area of hypoperfusion. A therapeutically effective dose ranges from about 1000-5500 mg of body weight and may be administered up to 72 hours after the onset of hemorrhage.

    Abstract translation: 蛛网膜下腔出血后交叉血红蛋白输注显着降低灌注不足的组织面积,并减少灌注不足区域神经元损伤的程度。 治疗有效剂量范围为约1000-5500mg体重,并且可以在出血发作后至多72小时施用。

Patent Agency Ranking